ArticleBMC family practice2019
Community pharmacy integration within the primary care pathway for people with long-term conditions: a focus group study of patients', pharmacists' and GPs' experiences and expectations.
Article in BMC family practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
59 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Developing a quality framework for community pharmacy: a systematic review of international literature.BMJ open · 2024Pooled it
- A qualitative exploration of informal carers' experiences with medication management and accessing community pharmacy support for people with long-term conditions.Exploratory research in clinical and social pharmacy · 2026Article
- Physicians' Perspectives on Collaboration with Community Pharmacists: Implications for Collaborative Care in Jordan.Healthcare (Basel, Switzerland) · 2026Article
- Discretion at the margins: An observational study of community pharmacists' adaptive practices in supporting migrant and ethnic minority health.Exploratory research in clinical and social pharmacy · 2026Article
- Examining public perceptions of cardiovascular disease risk screening programs in community pharmacies: a mixed-methods study.BMC public health · 2026Article
- Knowledge, attitudes, and practices of pharmacists towards chronic kidney disease in Rawalpindi and Islamabad, Pakistan: a cross-sectional study.BMC medical education · 2026Article
- Linking health literacy to medication adherence in chronic disease management from a community pharmacy perspective.Frontiers in public health · 2026Article
- Understanding collaborative working between GPs and community pharmacists: systematic review and thematic synthesis of qualitative studies.BJGP open · 2025Article
- No Time for Waste! Co-Producing Practice Guidelines and Research Recommendations to Promote Earlier Diagnosis of Colorectal Cancer in Community Pharmacies: A Qualitative Analysis.Health expectations : an international journal of public participation in health care and health policy · 2025Article
- Article
- Barriers and enablers to pharmacist involvement in social prescribing: a protocol for a systematic review of qualitative studies.BMJ open · 2025Article
- Article
- Strategic interventions and a novel model for the integration of community pharmacy and primary care in Spain: qualitative insights.BMJ open · 2024Article
- What are the priorities for improving quality for community pharmacy professional services? Nominal group technique discussions with multiple stakeholders.BMC health services research · 2024Article
- Environmental and personal barriers encountered in community pharmacy settings based on public opinions.Future science OA · 2024Article
- Assessing the Impact of a Leadership Development Programme for Community Pharmacy Neighbourhood Leads in South East London.Pharmacy (Basel, Switzerland) · 2024Article
- Knowledge, attitudes, and practices of primary healthcare practitioners regarding pharmacist clinics: a cross-sectional study in Shanghai.BMC health services research · 2024Article
- 'I think we could probably do more': an interview study to explore community pharmacists' experiences and perspectives of frailty and optimising medicines use in frail older adults.Age and ageing · 2024Article
- Workforce development in community pharmacies in England: Opportunities and tensions for a private sector provider of NHS services.PloS one · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to use marketing theory to examine the views of patients, pharmacists and general practitioners (GPs) on how community pharmacies are currently used and to identify how community pharmacy services may be better integrated within the primary care pathway for people with long-term conditions (LTCs).
methodsA qualitative research design was used. Two focus groups were conducted with respiratory patients (n = 6, 5) and two with type 2 diabetes patients (both n = 5). Two focus groups were held with pharmacists (n = 7, 5) and two with GPs (both n = 5). The "7Ps marketing mix" ("product", "price", "place", "promotion", "people", "process", "physical evidence") was used to frame data collection and analysis. Data was analysed using thematic analysis.
resultsDue to the access and convenience of community pharmacies ("place"), all stakeholder groups recommended using community pharmacies over GP practices for services such as management of minor ailments, medication reviews and routine check-ups for well managed LTCs ("product"). All stakeholder groups preferred pharmacy services with clear specifications which focused on specific interventions to reduce variability in service delivery and quality ("process"). However, all stressed the importance of having an appropriate system to share relevant information, allowing pharmacists and GPs two-way flow ("process"). Pharmacists and GPs mentioned difficulties in collaborating with each other due to inter-professional tensions arising from funding conflicts, which leads to duplication of services and inefficient workflow within the primary care pathway ("people"). Patients and GPs were sometimes doubtful of community pharmacies' potential to expand services due to limited space, size and poor quality consultation rooms ("physical evidence"). However, all stakeholder groups recommended promoting community pharmacy services locally and nationally ("promotion"). Patients felt the most effective form of promotion was first-hand experience of high quality pharmacy services and peer word-of-mouth. The added value of using pharmacy services was faster access and convenience for patients, and freeing up GPs' time to focus on more complex patients ("value").
conclusionsUsing the 7Ps marketing mix highlighted factors which could influence utilisation and integration of community pharmacy services within the primary care pathway for patients with LTCs. Further research is needed to identify their relative importance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.